FDA Inspection
AstraZeneca ABAstraZeneca AB – FDA Inspection, Dec 1, 2022
Record Details
This FDA Inspection record concerns AstraZeneca AB, with an inspection on December 1, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- AstraZeneca AB
- Inspection Date
- December 1, 2022
- Product Type
- Drugs
View Company Profile
ID · 27c718fa-7c43-4bb4-8673-10c7d64f0095
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1248230
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of AstraZeneca AB
10| Date | Classification | Office | Project area |
|---|---|---|---|
| April 10, 2026 | Not classified | Office of Inspections and Investigations | |
| November 13, 2025 | NAI | Postmarket Assurance: Devices | |
| December 6, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 11, 2018 | VAI | Office of Inspections and Investigations | New Drug Evaluation |
| December 7, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for AstraZeneca AB
- FDA Inspection 1318264 - 2026-04-10
- FDA Inspection 1295446 - 2025-11-13
- FDA Inspection 1143443 - 2019-12-06
- FDA Inspection 1068727 - 2018-10-11
- FDA Inspection 1115572 - 2017-12-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.